Furthermore, high expression of FAK in breast cancer is related to activation of AKT (Schmitz et al, 2005) and to the overexpression of receptor molecules such as ErbB2/Her2 and EGFR (Lemmon, 2003). This evidence concerns the gene PTK2 and breast carcinoma.